TrialJournal of child and adolescent psychopharmacology2013

An open-label extension study of the safety and efficacy of risperidone in children and adolescents with autistic disorder.

Justine M Kent et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.